Last updated on March 2018

A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder


Brief description of study

The purpose of this study is to investigate the efficacy of JNJ-42165279 during 12 weeks of treatment in participants with Social Anxiety Disorder (SAD).

Detailed Study Description

This is a Phase 2a randomized (study drug assigned by chance), double-blind (neither the Investigator nor the participants know about the study intervention), placebo-controlled, parallel-group, multi-center study of JNJ-42165279 in participants with social anxiety disorder. Participants will receive 25 milligram (mg) JNJ-42165279 or matching placebo orally once-daily from Day 1 up to 12 weeks. Participants will primarily be assessed for the change from baseline in Liebowitz Social Anxiety Scale (LSAS) at Week 12. Safety will be monitored throughout the study.

Clinical Study Identifier: NCT02432703

Contact Investigators or Research Sites near you

Start Over

University of California at San ...

University of California at San Diego
La Jolla, CA United States
  Connect »

Hartford Hospital - Institute of ...

Hartford Hospital - Institute of Living
Hartford, CT United States
  Connect »

APG Research, LLC

APG Research, LLC
Orlando, FL United States
  Connect »

Rush University Medical Center

Rush University Medical Center
Chicago, IL United States
  Connect »

Massachusetts General

Massachusetts General
Boston, MA United States
  Connect »

Boston Center for Clinical Research, ...

Boston Center for Clinical Research, LLC
Natick, MA United States
  Connect »

Clinilabs

Clinilabs
New York, NY United States
  Connect »

The Medical Research Network, LLC

The Medical Research Network, LLC
New York, NY United States
  Connect »

Finger Lakes Clinical Research

Finger Lakes Clinical Research
Rochester, NY United States
  Connect »

Richmond Behavioural Associates

Richmond Behavioural Associates
Staten Island, NY United States
  Connect »

Lehigh Center for Clinical Research

Lehigh Center for Clinical Research
Allentown, PA United States
  Connect »

Berks Center for Clinical Research

Berks Center for Clinical Research
Reading, PA United States
  Connect »

Future Search Trials of Dallas

Future Search Trials of Dallas
Dallas, TX United States
  Connect »

PRA Health Sciences

PRA Health Sciences
Salt Lake City, UT United States
  Connect »

The Lyell McEwin Hospital

The Lyell McEwin Hospital
Adelaide, Australia
  Connect »

Peninsula Therapeutic & Research Group

Peninsula Therapeutic & Research Group
Frankston, Australia
  Connect »

Monash Alfred Psychiatry Research Centre

Monash Alfred Psychiatry Research Centre
Melbourne, Australia
  Connect »

The Melbourne Clinic

The Melbourne Clinic
Melbourne, Australia
  Connect »

Sir Charles Gairdner Hospital

Sir Charles Gairdner Hospital
Perth, Australia
  Connect »

Brain & Mind Research Institute

Brain & Mind Research Institute
Sydney, Australia
  Connect »

Chokka Center for Integrative Health

Chokka Center for Integrative Health
Edmonton, AB Canada
  Connect »

McMaster University

McMaster University
Hamilton, ON Canada
  Connect »

Nabil Philips - ON Canada

Nabil Philips - ON Canada
Mississauga, ON Canada
  Connect »

START Clinic for Mood and ...

START Clinic for Mood and Anxiety Disorders
Toronto, ON Canada
  Connect »

Centre for Addiction and Mental ...

Centre for Addiction and Mental Health
Toronto, ON Canada
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.